Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2026-2030

Market Size (2024)

USD 3.82 Billion

Market Size (2030)

USD 6.32 Billion

CAGR (2025-2030)

8.72%

Fastest Growing Segment

Portable

Largest Market

North America

Market Overview

The Oxygen Concentrators market was valued at USD 3.82 Billion in 2024 and is expected to reach USD 6.32 Billion by 2030 with a CAGR of 8.72%. A oxygen concentrators is a vital component of medical equipment that provides support to patients with low blood oxygen levels. Its purpose is to supply supplemental oxygen to patients, with a higher concentration than the atmosphere. This device receives air, purifies it, and delivers it to the patient. The operation of an oxygen concentrator is straightforward and easily understood. oxygen concentrators offer convenience, portability, safety, compactness, cost-effectiveness, and contribute to a reduced risk of heart attacks and respiratory illnesses. Furthermore, they promote improved mental clarity and overall mood.

Oxygen concentrators enable patients to travel with ease due to their lightweight nature, affordability, and enhanced efficacy. The significance of oxygen concentrators is evident in the global market, reflecting the lifestyle of patients. These devices are classified into continuous flow, pulse flow, and other types. Continuous flow units continuously emit oxygen, even during inhalation and exhalation. Pulse flow units detect inhalation and only deliver oxygen at that specific moment. While pulse dosages are suitable for many individuals, they may not be suitable for those with specific medical conditions.

For nocturnal or night shifts, doctors often recommend continuous flow machines, while pulse dose machines can be used throughout the day by many patients. Oxygen concentrators are utilized by patients with pulmonary disorders such as bronchitis, respiratory problems, lung cancer, and severe pneumonia. These devices can be used at home and in healthcare settings to fulfill the oxygen requirements of patients. Additionally, they are employed to generate oxygen-rich air in the atmosphere by extracting surrounding air, compressing it, purifying it, and eliminating nitrogen and other contaminants.

 

Key Market Drivers

Rising Incidences of Respiratory Diseases

The growing number of individuals diagnosed with respiratory diseases, such as lung cancer, chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and influenza, highlights the urgent need for effective oxygen therapy solutions. Chronic respiratory diseases impact over 550 million adults globally and represent a leading cause of mortality and long-term disability. Pediatric populations are also significantly affected, with asthma identified as the most prevalent chronic condition among children, currently impacting approximately 14% of this demographic a figure that continues to grow. Over the past thirty years, the prevalence of chronic respiratory conditions has increased by an estimated 40%, underscoring a mounting public health challenge with substantial implications for healthcare systems worldwide. Oxygen concentrators offer a breakthrough in medical technology by providing a convenient and versatile option for delivering oxygen to patients. This empowers individuals to manage their respiratory conditions more effectively, ultimately enhancing their overall quality of life.

The rising incidences of respiratory diseases have led to an increased demand for POCs in the healthcare market. These innovative devices not only help patients receive the oxygen they need outside of the hospital setting but also enable healthcare providers to extend their care beyond traditional boundaries. By facilitating home-based oxygen therapy, POCs reduce the burden on healthcare facilities, ensuring that patients can receive continuous care in the comfort of their own homes.

In addition to the numerous benefits for patients and healthcare providers, POCs also present a cost-effective solution. Unlike traditional oxygen therapy methods, which often require frequent cylinder refills or maintenance of stationary concentrators, POCs eliminate these inconveniences. This not only saves time and resources but also ensures a seamless and uninterrupted oxygen supply for patients, leading to improved treatment outcomes.

With their portability, convenience, and cost-effectiveness, POCs are revolutionizing the field of respiratory care. By meeting the demand for effective oxygen therapy solutions, POCs are making a significant impact on the lives of individuals with respiratory diseases, offering them newfound freedom, independence, and improved well-being.

Growing Preference for Home-Based Medical Care

Home-based medical care has emerged as a crucial aspect of modern healthcare, emphasizing the importance of oxygen concentrators that empower patients to receive treatment in the comfort of their own homes, without the need for hospitalization or frequent visits to clinics. In this context, oxygen concentrators have gained significant traction as a convenient and lightweight solution for delivering oxygen therapy to patients at home. The growing preference for home-based care has consequently led to a surge in the demand for POCs, as they offer a practical and efficient means of administering oxygen therapy outside of traditional healthcare settings.

Beyond the convenience and portability, they provide, POCs also hold the potential for substantial cost savings within healthcare systems. By enabling patients to receive oxygen therapy at home, POCs have the potential to reduce hospital stays, readmissions, and visits to emergency departments, thereby optimizing the allocation of healthcare resources. This cost-effectiveness is a key driving factor behind the integration of POCs into home-based care strategies, as healthcare providers recognize the value of leveraging these devices to enhance patient care and improve overall healthcare outcomes.

The emphasis on home-based medical care has underscored the need for portable medical devices, particularly POCs, that empower patients to receive treatment conveniently and effectively in their own homes. With their lightweight design and ability to deliver oxygen therapy outside of hospitals and clinics, POCs have become an indispensable tool in home-based care, offering not only enhanced patient comfort but also cost savings and resource optimization within healthcare systems.

Increasing Geriatric Population

The market is being driven by the aging population, which is prone to these ailments, as well as the growing demand for practical portable technology. The global population aged 60 and above is projected to rise from 1.1 billion in 2023 to 1.4 billion by 2030, with the most pronounced growth occurring in developing regions. This accelerated demographic shift presents critical challenges and opportunities for public health systems, necessitating strategic planning to address the increased demand for age-related healthcare services and chronic disease management. The market for oxygen concentrators will also be significantly affected by the increase in everyday exposure to environmental pollutants. Increasing urbanization and discretionary economic levels are the primary drivers fueling the expansion of the oxygen concentrators industry. Urbanization continues to be a dominant global trend, with 55% of the world’s population currently residing in urban centers. This urban share is projected to increase to 68% by 2050, driving substantial shifts in infrastructure demand, healthcare delivery models, and resource allocation across metropolitan regions. Moreover, the increasing healthcare expenditures and evolving lifestyles of individuals are two other significant market factors that will further propel the market for oxygen concentrators. 

As individuals age, their susceptibility to respiratory conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, and other lung-related ailments increases. These conditions often necessitate long-term oxygen therapy to effectively manage symptoms and enhance the overall quality of life. Consequently, the growing geriatric population directly contributes to the heightened prevalence of respiratory diseases, resulting in an increased demand for oxygen concentrators as an indispensable medical device for oxygen therapy.

In addition to their medical importance, POCs offer the necessary mobility and portability that enable the elderly population to maintain an active lifestyle while receiving the vital oxygen support, they require. The desire for active aging among the geriatric population significantly drives the demand for POCs, as these devices empower them to fully engage in their desired activities, promoting independence and overall well-being. By providing a seamless integration of oxygen therapy into their daily routines, POCs play a crucial role in facilitating an enhanced quality of life for the aging population.

Rise in Advanced Technologies

Manufacturers' use of advanced technologies in the production of oxygen concentrators is also driving market growth. By leveraging cutting-edge innovations, companies are able to develop oxygen concentrators with higher efficacy and lower costs, meeting the growing demand for oxygen concentrators. The market growth is fueled by investment funding and the implementation of appropriate reimbursement policies by both the government and private institutions. These initiatives provide a favorable environment for manufacturers to invest in research and development, leading to the creation of innovative and high-quality oxygen concentrators. Moreover, strategic activities such as mergers and acquisitions among organizations not only encourage collaboration but also create platforms for new market participants to enter and thrive in the industry.

In addition to these factors, the market expansion is expected to be driven by firms increasing their expenditure in the manufacturing of transportable pulse and continuous-flow oxygen concentrators. As the demand for oxygen concentrators continues to rise, manufacturers are investing more resources into developing and producing reliable and efficient devices. This trend is expected to contribute significantly to the overall growth and development of the market. Overall, the combination of advanced technologies, investment funding, reimbursement policies, and strategic activities is propelling the growth of the oxygen concentrator market. With continuous advancements and a focus on meeting the evolving needs of consumers, the market is poised for further expansion in the coming years.

Oxygen Concentrators Market

Download Free Sample Report

Key Market Challenges

Stringent Government Rules

The expansion of the medical device sector is being hindered by recent modifications to the FDA's approval process in several nations. These changes, which aim to ensure patient safety and product efficacy, have introduced additional complexities and hurdles that companies must navigate. As a result, the process of bringing innovative medical devices to market has become more challenging and time-consuming.

Moreover, the industry is not only grappling with regulatory obstacles but also facing a shortage of skilled specialists. The demand for experts in medical device development, manufacturing, and regulatory affairs far exceeds the available talent pool. This scarcity of skilled professionals further exacerbates the difficulties faced by companies in bringing their products to market efficiently. In addition, the limited understanding of advanced medical technologies among healthcare professionals and the general public poses a potential detriment to the industry's growth. It is crucial for both healthcare providers and patients to stay informed and educated about the latest advancements in medical devices to ensure their effective utilization and widespread adoption. The medical device sector is navigating through a complex landscape, with regulatory changes, talent shortages, and knowledge gaps posing significant challenges. Addressing these issues will be vital for the industry's sustained growth and the timely availability of innovative medical technologies to benefit patients worldwide.

Reimbursement Procedures

The expensive price of the product is one of the main obstacles that hinders the widespread use of oxygen concentrators. In emerging economies, where disposable cash is limited and the price of the product is higher compared to wealthier nations, the acceptance of oxygen concentrators is significantly restricted. Furthermore, the market expansion for these oxygen concentrators is facing additional challenges due to the president's stringent restrictions and reimbursement guidelines, which further impede their adoption and growth. As a result, many individuals in these emerging economies are unable to afford oxygen concentrators, which limits their access to this important technology. The high cost not only affects individual consumers, but also restricts the adoption of oxygen concentrators in industries and communities that could greatly benefit from their use.

Moreover, the stringent restrictions and reimbursement guidelines imposed by the president have created a regulatory environment that is unfavorable for the growth of the oxygen concentrators market. This not only discourages potential buyers, but also adds complexity and uncertainty for manufacturers and distributors. In order to overcome these challenges and promote the widespread use of oxygen concentrators, it is crucial to address the affordability issue by exploring cost reduction strategies and alternative financing options. Additionally, advocacy efforts and engagement with policymakers can help create a more favorable regulatory environment that encourages the adoption and growth of these oxygen concentrators.

By addressing these factors and working towards making oxygen concentrators more accessible and affordable, we can overcome the barriers that hinder their widespread use and unlock their potential to improve safety and efficiency in various industries and communities.

Key Market Trends

Increasing Prevalence of Chronic Respiratory Diseases

The global market for oxygen concentrators is experiencing significant growth due to the increasing number of patients in need. According to the World Health Organization, chronic obstructive lung disease (COPD) ranks as the third leading cause of death, responsible for 3.23 million fatalities. Research indicates a rising prevalence of respiratory conditions, necessitating the use of oxygen for breathing. Furthermore, the market's expansion is fueled by the demand for long-term oxygen therapy (LTOT) and the growing number of asthma patients. In order to meet the needs of all patients requiring oxygen concentrators, there is an emphasis on providing accessible and affordable solutions, supported by favorable government initiatives. These factors together are driving the expansion of the market for oxygen concentrators, ensuring that patients receive the vital support they need for improved quality of life.

Continuous New Product Launches

The increasing adoption of oxygen concentrators in developing countries, driven by rising incomes and advancements in technology, is expected to create significant opportunities for the oxygen concentrators market during the forecast period. With the global prevalence of chronic obstructive pulmonary disease (COPD) on the rise, particularly in countries like India and China, the demand for oxygen concentrators is projected to soar. This growing demand is further bolstered by companies' heightened investment in the production of continuous flow oxygen concentrators and pulse flow oxygen concentrators, which will fuel market growth in the coming years. As the need for respiratory support continues to increase, the oxygen concentrators market is poised for substantial expansion, offering a promising outlook for both manufacturers and patients alike.

Segmental Insights

Type Insights

Based on their type, Portable segment emerges as the fastest growing segment in the Global Global Oxygen Concentrators Market. Globally, healthcare systems are increasingly shifting from hospital-centric models to more cost-effective home and outpatient care solutions. Portable oxygen concentrators (POCs) cater precisely to this trend, enabling patients especially those with chronic respiratory illnesses to maintain oxygen therapy while staying at home or moving freely in public settings. This flexibility significantly enhances quality of life and reduces hospitalization costs, making POCs an attractive option for both providers and patients.

Today’s oxygen therapy users, particularly in developed economies, prioritize convenience, autonomy, and mobility. Portable oxygen concentrators are lightweight, compact, and battery-operated, allowing users to travel, work, and socialize without interruption. The rising demand from active elderly populations and younger patients with chronic respiratory disorders has accelerated the adoption of portable units over traditional stationary systems. Ongoing innovations in miniaturization, battery life extension, and noise reduction have transformed POCs into efficient, user-friendly devices. Leading manufacturers are investing heavily in R&D to develop next-generation units that deliver reliable oxygen output with lower weight and longer operational time. The market has responded positively to these improvements, pushing growth within the portable segment.

Technology Insights

Based on the technology, the continuous flow segment dominates the Global Global Oxygen Concentrators Market. Continuous flow oxygen concentrators are designed to deliver a constant, uninterrupted stream of oxygen typically measured in liters per minute (LPM) regardless of the patient’s breathing pattern. This feature is critical for patients with severe respiratory conditions such as COPD, pulmonary fibrosis, or late-stage chronic illnesses, where consistent oxygen saturation levels must be maintained. As such, clinicians and respiratory therapists frequently recommend continuous flow units for more complex cases, reinforcing demand for this technology.

Unlike pulse dose systems, which are more suitable for intermittent use, continuous flow concentrators are preferred in hospital, ICU, and long-term care settings where patients require around-the-clock oxygen support. The reliability of continuous delivery makes these units integral to clinical environments, particularly in acute and post-acute care, contributing significantly to the segment’s market share. Continuous flow concentrators are often required for use in conjunction with other medical devices such as CPAP machines, ventilators, and humidifiers. This interoperability is a key differentiator, especially for patients undergoing multi-modal respiratory therapy. Pulse dose systems generally cannot provide the volume or flow consistency needed for such integrations, making continuous flow technology the standard choice in complex treatment scenarios.

Oxygen Concentrators Market

Download Free Sample Report

Regional Insights

Based on region, North America region emerges as the largest market in the Global Oxygen Concentrators Market. North America, particularly the United States and Canada, is home to some of the most advanced healthcare systems in the world. The region boasts well-established hospitals, diagnostic centers, and home healthcare services. These systems are highly equipped to adopt and integrate advanced medical technologies such as oxygen concentrators, both in clinical settings and for home use. 

The region has a significant prevalence of respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and sleep apnea, particularly among the aging population. According to the CDC, millions of Americans are affected by these disorders, which creates a sustained demand for supplemental oxygen therapy. Oxygen concentrators are a primary non-invasive solution for long-term oxygen therapy (LTOT), thereby driving market growth. North America is undergoing a pronounced demographic shift, driven by rising life expectancy and sustained declines in birth rates. This aging trajectory is expected to intensify in the coming decades, with a marked expansion in the 60+ age segment. By 2030, approximately 20% of the U.S. population will be aged 65 and above, reflecting a substantial shift in the region’s age structure. This demographic transformation is not only reshaping healthcare demand but is also directly influencing the long-term growth outlook for age-dependent medical technologies, including oxygen concentrators.

The Asia Pacific market is expected to witness significant growth throughout the forecast period, driven by factors such as rising disposable income, increasing tobacco consumption, growing COPD patient population, improved healthcare infrastructure, heightened awareness and acceptance of advanced oxygen concentrators, and expanding aging population. Furthermore, the increasing number of elderly individuals in the Asia Pacific region is poised to propel the oxygen concentrators industry in the near future.

Recent Developments

  • In Janury 2025, Caire has introduced the IntenOxy 5, a new stationary oxygen concentrator, to the HME/DME market in the United States and Puerto Rico. The company has strategically positioned the IntenOxy 5 for distribution through home medical equipment and durable medical equipment providers, with a planned market expansion into Canada in the near term.
  • In October 2024, Inogen, Inc., a leader in medical technology specializing in home respiratory solutions, today announced the commercial launch of its Inogen® Rove 4™ Portable Oxygen Concentrator across the U.S. market. This strategic release reinforces Inogen’s commitment to expanding its portfolio of innovative, patient-centric oxygen therapy devices for the homecare sector.
  • In March 2024, Drive DeVilbiss Healthcare and Sanrai International have jointly launched the PulmO2 10L Oxygen Concentrator, a next-generation device engineered for global clinical application. Developed through a strategic partnership, the PulmO2 combines energy efficiency and robust performance tailored to meet the demands of diverse healthcare settings. The product’s development and launch received backing from the UK government’s Foreign, Commonwealth, and Development Office (FCDO), underscoring its significance in advancing international medical technology.

Key Market Players

  • Koninklijke Philips N.V.
  • Invacare Corporation
  • Teijin Limited
  • Precision Medical, Inc.
  • Drive DeVilbiss Healthcare LLC
  • Nidek Medical Products Inc.
  • Inogen Inc.
  • NGK Spark Plug Co., Ltd.
  • GCE Group
  • Linde Healthcare

By Type

By Technology

By Flowrate

By Application

By End User

By Region

  • Portable
  • Stationary
  • Continuous Flow
  • Pulse Flow
  • Continuous/Pulse Flow
  • 0-5l/min
  • 5-10l/min
  • Above 10l/min
  • COPD
  • Lung Cancer
  • Pneumonia
  • COVID-19
  • Others
  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Home Care
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

 

Report Scope:

In this report, the Global Oxygen Concentrators Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Oxygen Concentrators Market, By Type:

o   Portable

o   Stationary

  • Oxygen Concentrators Market, By Technology:

o   Continuous Flow

o   Pulse Flow

o   Continuous/Pulse Flow

  • Oxygen Concentrators Market, By Flow Rate:

o   0-5l/min

o   5-10l/min

o   Above 10l/min

  • Oxygen Concentrators Market, By Application:

o   COPD

o   Lung Cancer

o   Pneumonia

o   COVID-19

o   Others

  • Oxygen Concentrators Market, By End User:

o   Hospitals & Clinics

o   Ambulatory Care Centres

o   Home Care

o   Others

  • Oxygen Concentrators Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oxygen Concentrators Market.

Available Customizations:

Global Oxygen Concentrators market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Oxygen Concentrators Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Oxygen Concentrators Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Type (Portable, Stationary)

5.2.2.    By Technology (Continuous Flow, Pulse Flow, Continuous/Pulse Flow)

5.2.3.    By Flowrate (0-5l/min, 5-10l/min, Above 10l/min)

5.2.4.    By Application (COPD, Lung Cancer, Pneumonia, COVID-19, Others)

5.2.5.    By End Users (Hospitals & Clinics, Ambulatory Care Centres, Home Care, Others)

5.2.6.    By Region

5.2.7.    By Company (2024)

5.3.  Market Map

6.    North America Oxygen Concentrators Market Outlook

6.1.  Market Size & Forecast       

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Type

6.2.2.    By Technology

6.2.3.    By Flowrate

6.2.4.    By Application

6.2.5.    By End Users

6.2.6.    By Country

6.3.  North America: Country Analysis

6.3.1.    United States Oxygen Concentrators Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.           By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.           By Type

6.3.1.2.2.           By Technology

6.3.1.2.3.           By Flowrate

6.3.1.2.4.           By Application

6.3.1.2.5.           By End Users

6.3.2.    Canada Oxygen Concentrators Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.           By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.           By Type

6.3.2.2.2.           By Technology

6.3.2.2.3.           By Flowrate

6.3.2.2.4.           By Application

6.3.2.2.5.           By End Users

6.3.3.    Mexico Oxygen Concentrators Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.           By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.           By Type

6.3.3.2.2.           By Technology

6.3.3.2.3.           By Flowrate

6.3.3.2.4.           By Application

6.3.3.2.5.           By End Users

7.    Europe Oxygen Concentrators Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Type

7.2.2.    By Technology

7.2.3.    By Flowrate

7.2.4.    By Application

7.2.5.    By End Users

7.2.6.    By Country

7.3.  Europe: Country Analysis

7.3.1.    Germany Oxygen Concentrators Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           By Type

7.3.1.2.2.           By Technology

7.3.1.2.3.           By Flowrate

7.3.1.2.4.           By Application

7.3.1.2.5.           By End Users

7.3.2.    United Kingdom Oxygen Concentrators Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           By Type

7.3.2.2.2.           By Technology

7.3.2.2.3.           By Flowrate

7.3.2.2.4.           By Application

7.3.2.2.5.           By End Users

7.3.3.    Italy Oxygen Concentrators Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           By Type

7.3.3.2.2.           By Technology

7.3.3.2.3.           By Flowrate

7.3.3.2.4.           By Application

7.3.3.2.5.           By End Users

7.3.4.    France Oxygen Concentrators Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.           By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.           By Type

7.3.4.2.2.           By Technology

7.3.4.2.3.           By Flowrate

7.3.4.2.4.           By Application

7.3.4.2.5.           By End Users

7.3.5.    Spain Oxygen Concentrators Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.           By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.           By Type

7.3.5.2.2.           By Technology

7.3.5.2.3.           By Flowrate

7.3.5.2.4.           By Application

7.3.5.2.5.           By End Users

8.    Asia-Pacific Oxygen Concentrators Market Outlook

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Type

8.2.2.    By Technology

8.2.3.    By Flowrate

8.2.4.    By Application

8.2.5.    By End Users

8.2.6.    By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.    China Oxygen Concentrators Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           By Type

8.3.1.2.2.           By Technology

8.3.1.2.3.           By Flowrate

8.3.1.2.4.           By Application

8.3.1.2.5.           By End Users

8.3.2.    India Oxygen Concentrators Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           By Type

8.3.2.2.2.           By Technology

8.3.2.2.3.           By Flowrate

8.3.2.2.4.           By Application

8.3.2.2.5.           By End Users

8.3.3.    Japan Oxygen Concentrators Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           By Type

8.3.3.2.2.           By Technology

8.3.3.2.3.           By Flowrate

8.3.3.2.4.           By Application

8.3.3.2.5.           By End Users

8.3.4.    South Korea Oxygen Concentrators Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.           By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.           By Type

8.3.4.2.2.           By Technology

8.3.4.2.3.           By Flowrate

8.3.4.2.4.           By Application

8.3.4.2.5.           By End Users

8.3.5.    Australia Oxygen Concentrators Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.           By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.           By Type

8.3.5.2.2.           By Technology

8.3.5.2.3.           By Flowrate

8.3.5.2.4.           By Application

8.3.5.2.5.           By End Users

9.    South America Oxygen Concentrators Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Type

9.2.2.    By Technology

9.2.3.    By Flowrate

9.2.4.    By Application

9.2.5.    By End Users

9.2.6.    By Country

9.3.  South America: Country Analysis

9.3.1.    Brazil Oxygen Concentrators Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           By Type

9.3.1.2.2.           By Technology

9.3.1.2.3.           By Flowrate

9.3.1.2.4.           By Application

9.3.1.2.5.           By End Users

9.3.2.    Argentina Oxygen Concentrators Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           By Type

9.3.2.2.2.           By Technology

9.3.2.2.3.           By Flowrate

9.3.2.2.4.           By Application

9.3.2.2.5.           By End Users

9.3.3.    Colombia Oxygen Concentrators Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           By Type

9.3.3.2.2.           By Technology

9.3.3.2.3.           By Flowrate

9.3.3.2.4.           By Application

9.3.3.2.5.           By End Users

10. Middle East and Africa Oxygen Concentrators Market Outlook

10.1.             Market Size & Forecast        

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. By Type

10.2.2. By Technology

10.2.3. By Flowrate

10.2.4. By Application

10.2.5. By End Users

10.2.6. By Country

10.3.             MEA: Country Analysis

10.3.1. South Africa Oxygen Concentrators Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Type

10.3.1.2.2.         By Technology

10.3.1.2.3.         By Flowrate

10.3.1.2.4.         By Application

10.3.1.2.5.         By End Users

10.3.2. Saudi Arabia Oxygen Concentrators Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Type

10.3.2.2.2.         By Technology

10.3.2.2.3.         By Flowrate

10.3.2.2.4.         By Application

10.3.2.2.5.         By End Users

10.3.3. UAE Oxygen Concentrators Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Type

10.3.3.2.2.         By Technology

10.3.3.2.3.         By Flowrate

10.3.3.2.4.         By Application

10.3.3.2.5.         By End Users

11. Market Dynamics

11.1.   Drivers

11.2.   Challenges

12. Market Trends & Developments

12.1.   Recent Developments

12.2.   Product Launches

12.3.   Mergers & Acquisitions

13. Global Oxygen Concentrators Market: SWOT Analysis

14. Competitive Landscape

14.1.   Koninklijke Philips N.V.

14.1.1.       Business Overview

14.1.2.       Product & Service Offerings

14.1.3.       Recent Developments

14.1.4.       Financials (If Listed)

14.1.5.       Key Personnel

14.1.6.       SWOT Analysis

14.2.   Invacare Corporation

14.3.   Teijin Limited

14.4.   Precision Medical, Inc.

14.5.   Drive DeVilbiss Healthcare LLC

14.6.   Nidek Medical Products Inc.

14.7.   Inogen Inc.

14.8.   NGK Spark Plug Co., Ltd.

14.9.   GCE Group

14.10.Linde Healthcare

15. Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Global Oxygen Concentrators Market was estimated to be USD 3.82 Billion in 2024.

Koninklijke Philips N.V., Invacare Corporation, Teijin Limited, Precision Medical, Inc., Drive DeVilbiss Healthcare LLC were the key players in the Global Oxygen Concentrators Market in 2024.

Stringent Government Rules and Reimbursement Procedures are the major challenges which restrict the growth of the Global Oxygen Concentrators Market.

Rising Incidences of Respiratory Diseases and Growing Preference for Home-Based Medical Care are the major drivers for the Global Oxygen Concentrators Market.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.